A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Marshall Pillay joins OKRA

   by Marina Gonzalo, Contributor    135    Comments 0

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Cambridge, UK, October 5th 2020 - OKRA is thrilled to announce the appointment of Marshall Pillay as VP Commercial - Europe and International. Starting today, Marshall will join OKRA from AKTANA, where he was most recently GM of Europe, responsible for all business and operations in the continent.

Previously, Marshall has also held director positions at Ernst & Young and IMS health, where he specialised in commercial excellence, data, analytics and SaaS-based solutions for Life Sciences.

 

“I’m delighted that Marshall is joining OKRA to further expand our European and global presence, and implement our best in-class AI solutions for all Life Sciences. His international experience in scaling enterprise-wide solutions for Pharma will be invaluable for OKRA’s next chapter,” said Dr Loubna Bouarfa, CEO and Founder of OKRA.

 

Marshall joins at a particularly exciting time for OKRA, as the company is experiencing unprecedented growth across the sector. The OKRA team are bringing their AI vision to life with key client partnerships across commercialmedical and market access, supporting Life Science companies to be fit and ready for a post COVID world.

 

Marshall Pillay: “It’s very clear to me where the future is, in the new world post COVID, life sciences require new products to help drive outcomes and OKRA definitely has the suite of scalable solutions Pharma companies have been looking for! Having seen the products first hand, there is no doubt in my mind that OKRA has the technology to make a huge impact worldwide for both Large Pharma and SMEs.”

 

About OKRA Technologies
OKRA founded in 2015, is a technology company transforming life sciences with Artificial Intelligence solutions. The company combines advanced AI with a hybrid explainability engine to drive commercial, medical and market access outcomes in life sciences. The company has developed the ‘OKRA Engine’, a leading AI Engine that is driving predictions, suggestions and reasons in real time to empower users to make smarter decisions with evidence based outputs. OKRA Technologies is headquartered in Cambridge (UK) with an additional office in Leiden (Netherlands).

 

Request a demo

Share this:              
A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D
 

Comments:

There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *